Pharmaceuticals and Medical Devices Agency

Events and Symposia

Public comments

What's new

December 25, 2025

Review

New

English Translation of Review Report: Hympavzi
December 25, 2025

Int

New

Report of PMDA-ATC Herbal Medicine Review Seminar 2025 has been posted
December 24, 2025

Safety

New

MHLW Pharmaceuticals and Medical Devices Safety Information No.425 posted
December 23, 2025

Review

List of Approved CDx（Companion Diagnostics）: Updated Dec 16, 2025
December 23, 2025

Review

List of Approved Products: April 2015 to November 2025
December 22, 2025

Events

The 11th Thailand-Japan Symposium
December 18, 2025

Review

Considerations for Non-clinical Studies of Combination Prescription Drugs with Similar Formulations(Early Consideration) posted
December 18, 2025

Other

Recent Publications by PMDA Staff updated
December 17, 2025

Review

List of Approved Drugs: April 2004 to June 2025

Back number

December 24, 2025

All

New

MHLW Pharmaceuticals and Medical Devices Safety Information No.425 posted

Back number

Currently, there is no applicable information.

Back number

December 18, 2025

Other

Recent Publications by PMDA Staff updated

Back number

December 25, 2025

Drug

Devices

New

Report of PMDA-ATC Herbal Medicine Review Seminar 2025 has been posted

Back number

Services of PMDA

Reviews and Related Services

Clinical trials, reviews, consultations, compliance assessments, and inspections concerning applications for drugs, medical devices, regenerative medical products, etc.

Post-marketing Safety Measures

Collection and provision of information regarding post-marketing safety and scientific research and analyses on data collected.

Relief Services for Adverse Health Effects

Relief Systems for Adverse Drug Reactions.

Regulatory Science

Regulatory science research, the Science Board, projects across multi-offices in PMDA, and standards development (e.g., Japanese Pharmacopoeia, medical device standards).

International Activities

International harmonization activities such as collaboration with overseas regulatory authorities and international organizations, participation in international meetings including ICH, and activities related to Asia Training Center.